non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years old, gender is not limited; 2. Non-small cell lung cancer diagnosed by pathology (tissue or cytology) (according to the 2015 version of the World Health Organization's histological classification of lung cancer); 3. Subjects with stage IIIB-IV NSCLC confirmed by histology or cytology according to the 8th edition of the TNM staging of lung cancer of the International Association for the Study of Lung Cancer and the American Joint Committee on Cancer Classification (attached documents); 4. The expected survival period is 3 months or more; 5. ECOG score: <= 2 points; 6. The investigator has at least one measurable lesion according to the efficacy evaluation of RECIST 1.1 standard; 7. Those who voluntarily participate in this research can follow up as required and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Combined with any other primary malignant tumors; 2. Pregnant or lactating women; 3. Patients who are fertile but unwilling or unable to take effective contraceptive measures; 4. Patients with drug abuse and medical, psychological or social conditions that may interfere with participation in the research or have an impact on the research results; 5. Patients without current address and fixed contact information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective response rate;Disease control rate;Fact-L4.0 scale score;Lung cancer Chinese medicine symptom scale score;Expression levels of peripheral blood T lymphocyte subsets (CD4+T cells, CD8+T cells, CD4+/CD8+T cells, NK cells); | — |
Countries
China
Contacts
Peking University People's Hospital